BCG Vaccine Market Size (USD 74.26 Million by 2030): Growth Prospects, Innovations, and Competitive Landscape to 2032

The BCG vaccine is a vaccine used to prevent tuberculosis (TB). It is made from a weakened strain of Mycobacterium bovis, a bacterium that causes TB in cattle. The vaccine works by stimulating the body's immune system to recognize and fight the TB bacteria. The BCG vaccine is typically given to infants in countries where TB is common, as well as to healthcare workers who are at increased risk of exposure to TB.

Allied Market Research has published a study report with the title BCG Vaccine Market Size was Valued at USD 46.63 Million in 2020 and is Anticipated to Garner USD 74.26 Million by 2030, registering a CAGR of 4.8% from 2021 to 2030.

𝐑𝐢𝐬𝐞 𝐢𝐧 𝐩𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞 𝐨𝐟 𝐭𝐮𝐛𝐞𝐫𝐜𝐮𝐥𝐨𝐬𝐢𝐬, 𝐞𝐬𝐩𝐞𝐜𝐢𝐚𝐥𝐥𝐲 𝐢𝐧 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐢𝐧𝐠 𝐚𝐧𝐝 𝐮𝐧𝐝𝐞𝐫𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐞𝐝 𝐜𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬, 𝐚𝐧𝐝 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭 𝐢𝐧 𝐭𝐡𝐞 𝐟𝐢𝐞𝐥𝐝 𝐨𝐟 𝐯𝐚𝐜𝐜𝐢𝐧𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐝𝐫𝐢𝐯𝐞 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐁𝐂𝐆 𝐯𝐚𝐜𝐜𝐢𝐧𝐞 𝐦𝐚𝐫𝐤𝐞𝐭. 𝐎𝐧 𝐭𝐡𝐞 𝐨𝐭𝐡𝐞𝐫 𝐡𝐚𝐧𝐝, 𝐜𝐞𝐫𝐭𝐚𝐢𝐧 𝐬𝐢𝐝𝐞 𝐞𝐟𝐟𝐞𝐜𝐭𝐬 𝐚𝐧𝐝 𝐠𝐥𝐨𝐛𝐚𝐥 𝐬𝐡𝐨𝐫𝐭𝐚𝐠𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐯𝐚𝐜𝐜𝐢𝐧𝐞 𝐢𝐦𝐩𝐞𝐝𝐞 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐭𝐨 𝐬𝐨𝐦𝐞 𝐞𝐱𝐭𝐞𝐧𝐭. 𝐇𝐨𝐰𝐞𝐯𝐞𝐫, 𝐮𝐧𝐭𝐚𝐩𝐩𝐞𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐢𝐧𝐠 𝐞𝐜𝐨𝐧𝐨𝐦𝐢𝐞𝐬 𝐡𝐚𝐯𝐞 𝐛𝐞𝐞𝐧 𝐡𝐢𝐠𝐡𝐥𝐲 𝐛𝐞𝐧𝐞𝐟𝐢𝐜𝐢𝐚𝐥 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐫𝐨𝐰𝐭𝐡.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞:
https://www.alliedmarketresearch.com/request-sample/4419

𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐟 𝐁𝐂𝐆 𝐕𝐚𝐜𝐜𝐢𝐧𝐞𝐬

• AJ Biologics
• China National group corporation (Sinopharm)
• Greensignal Biopharma Limited
• Intervax Ltd.
• Japan BCG Laboratory
• Merck & Co., Inc.
• Sanofi
• Serum Institute of India Pvt. Ltd.
• Stetens Serum Institute
• Torlak Institute of Virology

𝐁𝐂𝐆 𝐕𝐚𝐜𝐜𝐢𝐧𝐞𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

By demographics, the pediatrics segment generated the highest share in 2020, holding more than three-fourths of the global BCG vaccine market. The same segment is also expected to cite the fastest CAGR of 5.0% from 2021 to 2030, owing to an increase in the prevalence of tuberculosis, especially in developing and underdeveloped countries, and technological advancements in the field of vaccine research.

By region, Asia-Pacific contributed to the major market share in terms of revenue in 2020, holding nearly two-fifths of the global BCG vaccine market. The same region is also projected to cite the fastest CAGR of 5.3% from 2021 to 2030. This is attributed to improvements in healthcare infrastructure, rise in the number of hospitals equipped with advanced medical facilities, and developments in the R&D sector in the region

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/purchase-enquiry/4419

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.